G
Geron Corporation
GERN · NASDAQ · Healthcare · 943M
Price · close
$1.52
-1.94% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.5×
Enterprise value / EBITDAEV/EBITDA
-22.8×
Free cash flow yieldFCF yield
-11.0%
Return on equityROE
-38.0%
Operating margin
-29.3%
Net debt / EBITDAbalance-sheet strength
-3.3×
Interest coverage
-1.6×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.